4DMedical Limited

Equities

4DX

AU0000095416

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:51 2024-04-24 am EDT 5-day change 1st Jan Change
0.6 AUD -1.64% Intraday chart for 4DMedical Limited +5.26% -16.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
4DMedical Limited(ASX:4DX) added to S&P/ASX All Ordinaries Index CI
4DMedical Ties Up with Vanderbilt University Medical Center for Veterans’ Respiratory Disease Research; Shares Up 4% MT
4DMedical Narrows H1 FY24 Loss as Revenue Jumps 63% MT
4DMedical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
4DMedical Secures Research Agreement with US Department of Veterans Affairs MT
4DMedical Signs Distribution Deal for Imbio Medical Imaging AI Services MT
4DMedical's Operating Revenue Soars 60% in Fiscal H1 MT
4DMedical Enters Deal with Healthcare Company Philips to Expand XV Technology Commercialization; Shares Up 5% MT
Transcript : 4DMedical Limited - Shareholder/Analyst Call
Transcript : 4DMedical Limited - Special Call
4DMedical Acquires Imbio MT
Transcript : 4DMedical Limited, Imbio, LLC - M&A Call
Transcript : 4DMedical Limited - Special Call
Australian Shares Close Higher on Easing Inflation in October MT
4DMedical Signs MoU to Expand Lung Ventilation Technology in the US MT
4DMedical Receives U.S. FDA Clearance for CT LVAS Lung Function Scanning Software CI
Australian Shares Flat Amid Expectations of Economic Growth Rut MT
4DMedical Secures US Contracts for Lung Analysis Software MT
Oil Price Rally Buoys Australian Shares MT
US FDA Clears 4DMedical's CT LVAS Product; Shares Jump 14% MT
US CMS Assigns 4DMedical as Reimbursement Benefit for XV LVAS; Shares Jump 46% MT
4DMedical Limited Announces Resignation of Evonne Collier as a Non-Executive Director, Chair of the Remuneration and Nomination Committee CI
4DMedical Enters Agreement with Integral Diagnostics for XV Technology Distribution; Shares Jump 9% MT
4DMedical Appoints Chair MT
4DMedical Limited Announces Board Changes CI
Chart 4DMedical Limited
More charts
4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This technology powers its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA), which is a modality to dynamically quantify ventilation throughout the lungs, and its Computed Tomography-enabled counterpart software, CT LVAS. XV LVAS and CT LVAS reports are prepared using the Company’s software as a service (SaaS) delivery model using existing hospital imaging equipment or the Company's XV Scanner. It initiated the commercial rollout of XV LVAS with I-MED Radiology Network (I-MED), which is a diagnostic imaging provider with approximately 250 clinics nationwide. The Company provides its lung imaging technology to other selected clinics across the I-MED network.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.6 AUD
Average target price
1.133 AUD
Spread / Average Target
+88.89%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4DX Stock
  4. News 4DMedical Limited
  5. 4DMedical Names New CFO; Shares Up 4%